Lisdexamfetamine Dimesylate
"Lisdexamfetamine Dimesylate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
| Descriptor ID |
D000069478
|
| MeSH Number(s) |
D02.092.471.683.152.110.200.500
|
| Concept/Terms |
Lisdexamfetamine Dimesylate- Lisdexamfetamine Dimesylate
- Dimesylate, Lisdexamfetamine
- Lis-dexamfetamine Dimesylate
- Dimesylate, Lis-dexamfetamine
- Lis dexamfetamine Dimesylate
|
Below are MeSH descriptors whose meaning is more general than "Lisdexamfetamine Dimesylate".
Below are MeSH descriptors whose meaning is more specific than "Lisdexamfetamine Dimesylate".
This graph shows the total number of publications written about "Lisdexamfetamine Dimesylate" by people in this website by year, and whether "Lisdexamfetamine Dimesylate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lisdexamfetamine Dimesylate" by people in Profiles.
-
Variability of kinematic graphomotor fluency in adults with ADHD. Hum Mov Sci. 2014 Dec; 38:331-42.
-
Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate. Postgrad Med. 2014 Sep; 126(5):31-41.
-
Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study. J Atten Disord. 2017 Dec; 21(14):1198-1207.
-
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design. J Clin Psychiatry. 2012 Jul; 73(7):977-83.
-
Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD. Postgrad Med. 2011 May; 123(3):99-108.
-
Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity. Curr Med Res Opin. 2011 Jun; 27(6):1097-107.
-
Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Postgrad Med. 2011 Mar; 123(2):169-76.
-
Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults. Curr Med Res Opin. 2011; 27 Suppl 2:23-33.
-
Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. Postgrad Med. 2010 Sep; 122(5):7-17.
-
Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Curr Med Res Opin. 2010 Aug; 26(8):1809-25.